Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

Scalp nerve blocks plus dexmedetomidine to reduce opioids after brain tumor surgery

Official title: Perioperative Multimodal Analgesia for Supratentorial Craniotomy:Protocol for a 2× 2 Factorial Randomized Trial

Run by Beijing Tiantan Hospital · NCT07441421 · Data updated 2026-11-12

This trial tests whether scalp nerve blocks and/or dexmedetomidine can reduce opioid needs and help prevent delirium after supratentorial brain tumor surgery.

More Postoperative Pain trials

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment2000 (estimated)
SponsorBeijing Tiantan Hospital
Academic / other
Locations1 site (Beijing)
StatusRecruiting
StartedMarch 9, 2026
Main results expectedDecember 31, 2027
Study endsDecember 31, 2027
Registry record updatedOctober 15, 2026
Trial IDNCT07441421 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18–65 years old scheduled for elective supratentorial tumor resection with ASA I–III.

Probably not a fit

Patients with incision-site infection, prior craniotomy, certain heart conditions, severe hepatic/renal dysfunction, or allergies to study drugs may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a randomized, double-blind, placebo-controlled study using a 2x2 factorial design to test two non-opioid strategies in adults undergoing elective supratentorial tumor resection. Participants are assigned to receive either active scalp nerve blocks, active dexmedetomidine infusion, both, or neither, with outcomes comparing opioid use and delirium incidence. The study plans to enroll 2000 patients at a single center in Beijing, with strict eligibility and safety criteria. The design aims to determine the individual and combined effects of these non-opioid analgesic approaches.

Why it matters

Potential benefit: If successful, the approach could reduce opioid requirements and lower delirium risk after brain tumor surgery.

How similar studies have gone: Previous work in multimodal analgesia suggests benefit in postoperative pain; this specific factorial strategy in supratentorial surgery is a novel evaluation.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Aged from 18 to 65 years
* American Society of Anesthesiologists physical status I to III
* Scheduled to undergo elective supratentorial tumor resection

Exclusion Criteria:

* Incision-area skin infection
* A history of previous craniotomy
* Allergy to study medications
* A history of preoperative change in consciousness or cognitive function
* Inability to communicate,
* Preoperative pain in the surgical region
* Severe hepatic or renal dysfunction
* Severe bradycardia (heart rate\<40 beats/min)
* Sick sinus syndrome or second- to-third degree atrioventricular block

Where it's running

  • Beijing Tian Tan Hospital, Capital Medical University
    Beijing, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.